Click to view our accessibility statement Skip to main content
By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.
This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences and hosted by Current Psychiatry.
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Real-World Patients
  4. 70-Year Old Woman With Tardive Dyskinesia Displaying Oro-Buccal-Lingual Stereotypy
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Real-World Patients
  4. 70-Year Old Woman With Tardive Dyskinesia Displaying Oro-Buccal-Lingual Stereotypy

Case Studies

70-Year Old Woman With Tardive Dyskinesia Displaying Oro-Buccal-Lingual Stereotypy

    Share:
  • share via your computer's mail program
3-min watch


FACULTY CONTRIBUTOR

Portrait picture of Richard M. Trosch, MD
Richard M. Trosch, MD
Associate Professor
Department of Neurology
Oakland University William Beaumont School of Medicine
Rochester, MI

Recommended Next

360-Degree Impact of Tardive Dyskinesia: Functional, Emotional, and Social Impact
Read More | 9-min read
Impact of Tardive Dyskinesia on Broader Mental Well-Being
Read More | 4-min read
Screening for Tardive Dyskinesia via Telehealth With The MIND-TD Questionnaire
Watch Now | 26-min watch

    Share:

  • share via your computer's mail program
Neurocrine Biosciences logo
  • Privacy Policy |
  • Cookie Policy |
  • Terms & Conditions |
  • Accessibility
©2022 Neurocrine Biosciences, Inc. All Rights Reserved.
MED-MSL-TD-US-0249 v2 CP-TD-US-0744 v3 07/2022
The MIND-TD website and educational content were sponsored and co-developed by Neurocrine Biosciences, Inc. The faculty have been compensated by Neurocrine Biosciences. This non-CME program is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient. The content did not undergo peer review by Current Psychiatry.